Cite
National utilization of regional lymph node dissection among patients with kidney cancer and clinical lymphadenopathy undergoing radical nephrectomy
MLA
Matthew J. Bream, et al. “National Utilization of Regional Lymph Node Dissection among Patients with Kidney Cancer and Clinical Lymphadenopathy Undergoing Radical Nephrectomy.” Cancer Treatment and Research Communications, vol. 12, Jan. 2017, pp. 14–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3f36f07ceb6d94f1c54ef732532bab0e&authtype=sso&custid=ns315887.
APA
Matthew J. Bream, Marc C. Smaldone, Simon P. Kim, Stephen A. Boorjian, Stephen B. Williams, Nilay Shah, Chris M. Gonzalez, Robert Houston Thompson, Alexander Kutikov, & Robert Abouassaly. (2017). National utilization of regional lymph node dissection among patients with kidney cancer and clinical lymphadenopathy undergoing radical nephrectomy. Cancer Treatment and Research Communications, 12, 14–18.
Chicago
Matthew J. Bream, Marc C. Smaldone, Simon P. Kim, Stephen A. Boorjian, Stephen B. Williams, Nilay Shah, Chris M. Gonzalez, Robert Houston Thompson, Alexander Kutikov, and Robert Abouassaly. 2017. “National Utilization of Regional Lymph Node Dissection among Patients with Kidney Cancer and Clinical Lymphadenopathy Undergoing Radical Nephrectomy.” Cancer Treatment and Research Communications 12 (January): 14–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3f36f07ceb6d94f1c54ef732532bab0e&authtype=sso&custid=ns315887.